Invention Grant
US08946174B2 Tumor antigens BFA4 and BCY1 for prevention and / or treatment of cancer
有权
用于预防和/或治疗癌症的肿瘤抗原BFA4和BCY1
- Patent Title: Tumor antigens BFA4 and BCY1 for prevention and / or treatment of cancer
- Patent Title (中): 用于预防和/或治疗癌症的肿瘤抗原BFA4和BCY1
-
Application No.: US12888975Application Date: 2010-09-23
-
Publication No.: US08946174B2Publication Date: 2015-02-03
- Inventor: Neil Berinstein , Corey Lovitt , Mark Parrington , Artur Pedyczak , Laszlo Radvanyi , Scott Gallichan , Devender Singh-Sandhu , Raymond P. Oomen , Shi-Xian Cao
- Applicant: Neil Berinstein , Corey Lovitt , Mark Parrington , Artur Pedyczak , Laszlo Radvanyi , Scott Gallichan , Devender Singh-Sandhu , Raymond P. Oomen , Shi-Xian Cao
- Applicant Address: CA Toronto, Ontario
- Assignee: Sanofi Pasteur Limited
- Current Assignee: Sanofi Pasteur Limited
- Current Assignee Address: CA Toronto, Ontario
- Agent Patrick J. Halloran; Reza Yacoob
- Main IPC: A61K48/00
- IPC: A61K48/00 ; C12N15/00 ; C07K14/47 ; A61K39/00
Abstract:
The present invention relates to a nucleic acid encoding a polypeptide and the use of the nucleic acid or polypeptide in preventing and/or treating cancer. In particular, the invention relates to improved vectors for the insertion and expression of foreign genes encoding tumor antigens for use in immunotherapeutic treatment of cancer.
Public/Granted literature
- US20110117640A1 TUMOR ANTIGENS BFA4 AND BCY1 FOR PREVENTION AND / OR TREATMENT OF CANCER Public/Granted day:2011-05-19
Information query
